International Clinical Trials Autumn Issue Is Live

6 August 2026

The Rise of Chinese Biotechs and the Global CRO Question

What's fueling the surge of Chinese biotechs onto the world stage, and what decisions do they face on the path to their first global clinical trial?

27 May 2026

How Australia’s Leading CRO Is Driving Biotech’s Acceleration From First-In-Human To Global Markets

In 2025, Harvill’s experience overseeing CROs through global expansion across Asia Pacific (APAC), Europe, and South America led him to take the helm at Avance Clinical, Australia’s leading CRO.

11 March 2026

CNS Trials Are Difficult — Do They Have To Be?

Central nervous system (CNS) indications, including mood disorders, neurodegenerative and neurodevelopmental diseases, and chronic pain, affect more than three billion people worldwide and represent the leading cause of illness and disability globally1.

11 February 2026

Why Early CRO Choice Is Critical To Accelerating Delivery Of Your Clinical Program

Australia's pragmatic regulatory environment, accelerated timelines, globally accepted data, Research and Development Tax Incentive, and other advantages, have emerged as a compelling strategy for Phase I trials.

15 October 2025

Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination

• Asia Advantage

Globally, cancer diagnoses are projected to reach 35.3 million new cases per year with death rates rising to 18.5 million by 2050.²

15 October 2025

Unlocking the Potential of FDA Expedited Approval and Voucher Programs: An Avance Clinical Partnership Approach

• North America

Our integrated approach combines deep regulatory expertise with world-class operational resources to guide Sponsors through every aspect of these complex programs, from initial eligibility assessment to managing post-approval commitments.

23 September 2025

Accelerating Development Through Parallel Execution and Rigorous Quality Controls

In a recent video interview with Applied Clinical Trials, Ben Edwards, Chief Operating Officer, Avance Clinical, discussed common challenges in biotech, emphasizing the importance of addressing preclinical package gaps to avoid delays.

17 April 2025

Advancing Rare Disease Clinical Trials: A High-Touch, Patient-Centered Approach for Biotechs

Avance Clinical supports biotech companies by employing patient-centered trial designs, innovative statistical methodologies, personalized patient support, and expert regulatory guidance.

6 March 2025

Avance Clinical North America: Proven Expertise With Global Solutions For US Biotechs

• North America

The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

17 January 2025

Ensure Seamless Clinical Trial Transition Across Global Markets

To enable access to life-saving therapeutics, drug sponsors continue to explore new strategies for executing their clinical trials as rapidly and efficiently as possible.

5 January 2025

Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research

The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

20 December 2024

Navigating the Risks: Why Compassionate Use Should Not Replace Rigorous Clinical Trials

Recently, we have observed an increasing number of queries from clients exploring the potential of utilizing 'special access-like schemes' to obtain clinical data, as an alternative to conducting properly structured clinical trials, due to challenges in securing necessary funding.